| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.23 | 3e-08 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-08 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-08 |